zoledronic acid has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorstyn, L; Ho, LH; Kumar, S; Lambrusco, L; Read, SH | 1 |
| Arai, N; Hattori, Y; Inoue, S; Noguchi, M; Takashina, M; Tomihara, K | 1 |
2 other study(ies) available for zoledronic acid and cytochrome c-t
| Article | Year |
|---|---|
Caspase-2 is required for cell death induced by cytoskeletal disruption.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Bone Density Conservation Agents; Carrier Proteins; Caspase 2; Cells, Cultured; Colony-Forming Units Assay; CRADD Signaling Adaptor Protein; Cytochromes c; Cytoskeleton; Death Domain Receptor Signaling Adaptor Proteins; Diphosphonates; Fibroblasts; Imidazoles; Immunoblotting; Immunoenzyme Techniques; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Zoledronic Acid | 2008 |
Extracellular Ca(2+)-dependent enhancement of cytocidal potency of zoledronic acid in human oral cancer cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Calcium; Calcium Chelating Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cytochromes c; Diphosphonates; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Imidazoles; MCF-7 Cells; Membrane Potential, Mitochondrial; Mitochondria; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Zoledronic Acid | 2015 |